|
|
|
| |
CTSI is now on Facebook!

|
|
|
|
|
|
|
| |
Currently Enrolling
- eXtreme Lateral Total Disc Replacement
- Facet Replacement
- CoFlex
- Bone Marrow Aspirate Concentrate
- Lateral Interbody Fusion
- Mesoblast Stem Cell Fusion
|
|
|
|
|
|
|
| |
If you are a new or established patient, please complete our patient
satisfaction survey:

|
|
|
|
|
|
|
|
|
| |
The Anatomic Facet Replacement System (AFRS™)
was developed by Facet Solutions, Inc. It is intended as an
alternative to spinal fusion for patients suffering from back and leg pain due
to spinal stenosis.
We are currently enrolling patients for this U.S.
Food and Drug Administration (FDA) Clinical Trial.

Double click for more information on the AFRS study
|
|
|
|
|
|
|
| |
The Paradigm Spine - Coflex® is a
device designed to treat spinal stenosis, a condition
that can cause pain, weakness, numbness or other sensations in
the lower back, buttocks and legs.
We are currently enrolling patients in this
FDA-approved Clinical Trial.

Double click for more information on Coflex
study |
|
|
|
|
|
|
| |
Richard Wupperman, M.D. , is the principal investigator for this IRB-approved
clinical outcomes trial. The eXtreme Lateral Interbody Fusion (XLIF) uses
an FDA-approved device developed by Nuvasive, Inc. for minimally invasive spinal
fusion. It can be used to treat a variety of spinal disorders caused by
degenerative disc disease (DDD) in adults, including spondylosis,
spondylolisthesis, and scoliosis.
Dr. Wupperman is currently enrolling patients in this study.
In the XLIF, the surgeon performs the discectomy and fusion through a tube
placed through the patient's side. Patients must be between 18 and 89
years of age to participate.
For more information, please contact our study coordinator, Amy, via email
at studyinfo@pqrinc.com.
|
|
|
|
|
|
|
| |
Bone Marrow Aspirate Concentrate (BMAC) from SpineSmith is being compared to
the current gold-standard in spinal fusions, Bone Morphogenetic Protein (BMP).
We are currently enrolling patients for this U.S. Food and Drug Administration
(FDA) Randomized Clinical Trial. Please contact our office for more
information.
|
|
|
|
|
|
|
|
|